Key Questions on PARP Inhibitors in Ovarian Cancer: Experts Evaluate the Latest Evidence

Activity

Progress
1
Course Completed
Activity Information

Physicians: Maximum of 0.75 AMA PRA Category 1 Credit

Released: July 20, 2021

Expiration: July 19, 2022